Toll Free: 1-888-928-9744

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China

Published: Jan 18, 2016 | Pages: 258 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.

The population of China in 2014 was approximately 1.37 billion, having grown at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008. The country's increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical industry, which was estimated to be worth $106.5 billion in 2008 and is projected to reach $1,637.3 billion by 2020, at a CAGR of 25.6%. Approximately 95% of China's population has healthcare coverage. Improvements in drug safety and quality; a shorter drug registration timeline; the elimination of price caps by the government; a more transparent system for the approval of drugs and medical instruments; and an IPR regime are driving innovation in the pharmaceutical sector. These changes encourage foreign Multinational Companies (MNC) to invest in China. The Chinese medical device market is the second largest in Asia, valued at $27.7 billion in 2014 and projected to grow at a CAGR of 10.6% to an estimated $50.8 billion in 2020.

These growth trends can be primarily attributed to the following causes -

Sedentary lifestyles leading to a high chronic disease burden.
The accessibility of healthcare professionals in the remote areas of the county.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in China, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: GlaxoSmithKline, Pfizer, AstraZeneca, Harbin Pharmaceutical Group and Tianjin Tasly Pharmaceutical; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Philips, Medtronic and F. Hoffman La Roche
Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving China's healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect China's healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
Identify, understand, and capitalize on the opportunities and challenges in China's healthcare market
 Table of Contents

Table of Contents
1.1. List of Tables
1.2. List of Figures

2. Introduction
2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Markets
3.1. Pharmaceutical Market
3.1.1. Market Overview
3.1.2. Pharmaceutical Exports and Imports
3.1.3. Supply Channels
3.1.4. Market Segments
3.1.5. Overview of Top Five Disease Areas
3.1.6. Major Players
3.2. Medical Device Market
3.2.1. Market Overview
3.2.2. Overview of Top Five Segments
3.2.3. Diagnostic Market
3.2.4. Major Players
3.3. Market Drivers and Barriers
3.3.1. Drivers
3.3.2. Barriers

4. Market Access
4.1. Overview of the Healthcare System
4.2. Reimbursement and Payer Landscape
4.2.1. Reimbursement Process
4.2.2. Overview of Insurance Providers
4.2.3. Patient Share in Healthcare Spending
4.2.4. Prescription Drug Price Trend
4.2.5. Pricing Policies
4.3. Regulatory Landscape
4.3.1. Overview of Regulatory Agencies
4.3.2. Market Authorization Procedure for Pharmaceutical Products
4.3.3. Market Authorization Procedure for Medical Devices
4.3.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.3.5. Licensing Process for Pharmaceutical Exports and Imports
4.3.6. Intellectual Property Rights
4.3.7. Clinical Trial Regulations
4.3.8. Pharmaceutical Advertising Regulations
4.3.9. Pharmacy Regulations
4.3.10. Labeling and Packaging Regulations

5. Country Analysis
5.1. Political Environment
5.1.1. Political Structure
5.1.2. Analysis of the Current Political Environment
5.1.3. Healthcare Policy Initiatives
5.2. Economic Landscape
5.3. Economic Indicators
5.3.1. Gross Domestic Product
5.3.2. Gross National Income
5.3.3. Inflation
5.3.4. Currency Exchange Rate
5.3.5. Foreign Direct Investment
5.3.6. Foreign Exchange Reserves
5.3.7. Trade Balance
5.3.8. General Government Structural Balance
5.3.9. General Government Gross Debt
5.3.10. Major Industries
5.4. Demographics
5.4.1. Population
5.4.2. Education and Literacy Rate
5.4.3. Employment
5.4.4. Disease Burden
5.5. Healthcare Infrastructure
5.5.1. Hospitals
5.5.2. Healthcare Facilities
5.5.3. Healthcare Parameters
5.5.4. Environmental Health
5.5.5. Healthcare Personnel
5.6. Healthcare Expenditure
5.6.1. Overview
5.6.2. Public and Private Sector Share
5.7. Trade Associations
5.7.1. China Chamber of Commerce for Import and Export of Medicines and Health Products
5.7.2. China Healthcare Association
5.7.3. Shanghai Medical Instrument Trade Association
5.7.4. Chinese Hospital Association
5.7.5. China Pharmaceutical Industry Association
5.8. Trade Fairs

6. Opportunities and Challenges
6.1. Opportunities
6.2. Challenges

7. Appendix
7.1. Abbreviations
7.2. Bibliography
7.3. Research Methodology
7.3.1. Coverage
7.3.2. Secondary Research
7.3.3. Forecasts
7.3.4. Expert Panel
7.4. Disclaimer
List of Tables

Table 1: Pharmaceutical Market, China, Revenue ($bn), 2008-2014
Table 2: Pharmaceutical Market, China, Revenue Forecast ($bn), 2015-2020
Table 3: Pharmaceutical Market, China, Exports and Imports ($bn), 2008-2014
Table 4: GlaxoSmithKline, Global, Major Products, Revenue ($bn), 2014
Table 5: Late-stage Pipeline, GlaxoSmithKline, 2015
Table 6: Pharmaceutical Market, Pfizer, Global, Major Products, 2014
Table 7: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2015
Table 8: Major Products, AstraZeneca, Global, Revenue ($bn), 2014
Table 9: Late-stage Pipeline, AstraZeneca, 2015
Table 10: Major Products, Harbin Pharmaceuticals Group, 2015
Table 11: Major Products, Tasly, 2015
Table 12: Medical Device Market, China, Revenue ($bn), 2008-2014
Table 13: Medical Device Market, China, Revenue Forecast ($bn), 2014-2020
Table 14: Medical Device Market, China, Revenue by Segment, 2014
Table 15: Medical Device Market, China, Ophthalmic Devices Market, Revenue ($bn), 2008-2014
Table 16: Medical Device Market, China, Ophthalmic Devices Market, Market Share for Major Players, 2012
Table 17: Medical Device Market, China, Diagnostic Imaging Market, Revenue ($bn), 2008-2014
Table 18: Medical Device Market, China, Diagnostic Imaging Market, Market Share for Major Players, 2012
Table 19: Medical Device Market, China, In Vitro Diagnostic Market, Revenue ($bn), 2008-2014
Table 20: Medical Device Market, China, In Vitro Diagnostic Market, Market Share for Major Players, 2012
Table 21: Medical Device Market, China, Cardiovascular Device Market, Revenue ($bn), 2008-2014
Table 22: Medical Device Market, China, Cardiovascular Device Market, Market Share for Major Players, 2012
Table 23: Medical Device Market, China, Orthopedic Device Market, Revenue ($bn), 2008-2014
Table 24: Medical Device Market, China, Orthopedic Device Market, Market Share for Major Players, 2012
Table 25: Medical Device Market, China, Diagnostic Market, Revenue ($bn), 2008-2014
Table 26: Medical Device Market, China, Diagnostic Market, Revenue Forecast ($bn), 2015-2020
Table 27: Medical Device Market, China, Major Medical Device Companies, Revenue, 2012
Table 28: Medical Device Market, Major Products, Medtronic, 2014
Table 29: Healthcare Spending, China, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008-2014
Table 30: Market Access, China, Healthcare Consumer Price Index, 2008-2014
Table 31: Economic Indicators, China, GDP per Capita ($), 2008-2014
Table 32: Economic Indicators, China, GDP per Capita Forecast ($), 2015-2020
Table 33: Economic Indicators, China, GDP Growth (%), 2008-2014
Table 34: Economic Indicators, China, GDP Annual Growth Forecast (%), 2015-2020
Table 35: Economic Indicators, China, Gross National Income per Capita ($), 2008-2014
Table 36: Economic Indicators, China, Average Consumer Price Index, 2008-2014
Table 37: Economic Indicators, China, Average Consumer Price Index Forecast, 2014-2020
Table 38: Economic Indicators, China, Average Consumer Price Change (%), 2008-2014
Table 39: Economic Indicators, China, Currency Exchange Rate (CNY/$), 2008-2014
Table 40: Economic Indicators, China, Foreign Direct Investment ($bn), 2008-2014
Table 41: Economic Indicators, China, Foreign Exchange Reserves ($tn), 2008-2014
Table 42: Economic Indicators, China, Trade Balance ($bn), 2008-2014
Table 43: Economic Indicators, China, Imports of Goods and Services ($tn), 2008-2014
Table 44: Economic Indicators, China, Exports of Goods and Services ($tn), 2008-2014
Table 45: Economic Indicators, China, Government Structural Balance ($bn), 2008-2014
Table 46: Economic Indicators, China, General Government Gross Debt ($tn), 2008-2014
Table 47: Economic Indicators, China, Major Industries, GDP by production ($tn), 2013
Table 48: Demographics, China, Population (billion), 2008-2014
Table 49: Demographics, China, Population Forecast (billion), 2015-2020
Table 50: Demographics, China, Population, Urban and Rural Population (%), 2008-2013
Table 51: Demographics, China Population Distribution by Age Group (%), 2008-2014
Table 52: Demographics, China, Population Distribution by Age Group Forecast (%), 2014-2020
Table 53: Demographics, China, Births (per 1,000 Population), 2008-2014
Table 54: Demographics, China, Mortality (per 1,000 Population), 2008-2014
Table 55: Demographics, China, Major Causes of Mortality (per 1,000 population), 2011
Table 56: Demographics, China, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008-2014
Table 57: Demographics, China, Immunization (%), 2008-2014
Table 58: Demographics, China, Major Causes of Male Mortality (%), 2011
Table 59: Demographics, China, Major Causes of Female Mortality (%), 2011
Table 60: Demographics, China, Gender Ratio (Males per 100 Females), 2008-2014
Table 61: Demographics, China, Life Expectancy (Years), 2008-2014
Table 62: Demographics, China, Student Enrollment by Level of Education (million), 2014
Table 63: Demographics, China, Unemployment Rate in Urban Areas (%), 2008-2014
Table 64: Demographics, China, Major Diseases, City Hospital In-Patients (%), 2011
Table 65: Demographics, China, Major Diseases, Share of County Hospital In-Patients (%), 2011
Table 66: Demographics, China, Major Diseases, DALY (per 100,000 Population), 2009
Table 67: Healthcare Infrastructure, China, Hospitals, 2008-2014
Table 68: Healthcare Infrastructure, China, Hospitals by Bed Size (%), 2011
Table 69: Healthcare Infrastructure, China, Hospitals Beds (million), 2008-2014
Table 70: Healthcare Infrastructure, China, Hospital Beds (per 1,000 Population), 2008-2014
Table 71: Healthcare Infrastructure, China, Doctors (per 1,000 Population), 2008-2014
Table 72: Healthcare Infrastructure, China, CO2 Emissions (Metric Tons per Capita), 2008-2014
Table 73: Healthcare Infrastructure, China, PM10 Emissions (µg/m3), 2008-2014
Table 74: Healthcare Infrastructure, China, Nurses (per 1,000 Population), 2008-2014
Table 75: Healthcare Expenditure, China, Healthcare Expenditure (% of GDP), 2008-2014
Table 76: Healthcare Expenditure, China, Public-Private Share of Healthcare Expenditure (%), 2008-2014
Table 77: Trade Fairs, China, Major Healthcare Trade Fairs, 2015 


List of Figures

Figure 1: Pharmaceutical Market, China, Revenue ($bn), 2008-2014
Figure 2: Pharmaceutical Market, China, Revenue Forecast ($bn), 2015-2020
Figure 3: Pharmaceutical Market, China, Exports and Imports ($bn), 2008-2014
Figure 4: Pharmaceutical Distribution Channels, China, 2015
Figure 5: Medical Device Market, China, Revenue ($bn), 2008-2014
Figure 6: Medical Device Market, China, Revenue Forecast ($bn), 2014-2020
Figure 7: Medical Device Market, China, Revenue by Segment ($bn), 2014
Figure 8: Medical Device Market, China, Ophthalmic Devices Market, Revenue ($bn), 2008-2014
Figure 9: Medical Device Market, China, Ophthalmic Devices Market, Market Share for Major Players (%), 2012
Figure 10: Medical Device Market, China, Diagnostic Imaging Market, Revenue ($bn), 2008-2014
Figure 11: Medical Device Market, China, Diagnostic Imaging Market, Market Share for Major Players (%), 2012
Figure 12: Medical Device Market, China, In Vitro Diagnostic Market, Revenue ($bn), 2008-2014
Figure 13: Medical Device Market, China, In Vitro Diagnostic Market, Market Share for Major Players (%), 2012
Figure 14: Medical Device Market, China, Cardiovascular Device Market, Revenue ($bn), 2008-2014
Figure 15: Medical Device Market, China, Cardiovascular Device Market, Market Share for Major Players (%), 2012
Figure 16: Medical Device Market, China, Orthopedic Device Market, Revenue ($bn), 2008-2014
Figure 17: Medical Device Market, China, Orthopedic Device Market, Market Share for Major Players (%), 2012
Figure 18: Medical Device Market, China, Diagnostic Market, Revenue ($bn), 2008-2014
Figure 19: Medical Device Market, China, Diagnostic Market, Revenue Forecast ($bn), 2015-2020
Figure 20: Medical Device Market, China, Major Medical Device Companies, Revenue ($m), 2012
Figure 21: Healthcare Market, China, Drivers and Barriers, 2014
Figure 22: Healthcare System, China, Key Influences in Reimbursement Procedure, 2013
Figure 23: Healthcare Spending, China, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008-2014
Figure 24: Market Access, China, Healthcare Price Index, 2008-2014
Figure 25: Market Access, SFDA Structure, 2013
Figure 26: Healthcare System, China, New Drug Approval Process, 2013
Figure 27: Healthcare System, China, New Medical Device Approval Process, 2013
Figure 28: Economic Indicators, China, GDP per Capita ($), 2008-2014
Figure 29: Economic Indicators, China, GDP per Capita Forecast ($), 2015-2020
Figure 30: Economic Indicators, China, GDP Growth (%), 2008-2014
Figure 31: Economic Indicators, China, GDP Growth Forecast (%), 2015-2020
Figure 32: Economic Indicators, China Gross National Income per Capita ($), 2008-2014
Figure 33: Economic Indicators, China, Average Consumer Price Index, 2008-2014
Figure 34: Economic Indicators, China, Average Consumer Price Index Forecast, 2014-2020
Figure 35: Economic Indicators, China, Average Consumer Price Change (%), 2008-2014
Figure 36: Economic Indicators, China, Currency Exchange Rate (CNY/$), 2008-2014
Figure 37: Economic Indicators, China, Foreign Direct Investment ($bn), 2008-2014
Figure 38: Economic Indicators, China, Foreign Exchange Reserves ($tn), 2008-2014
Figure 39: Economic Indicators, China, Trade Balance ($bn), 2008-2014
Figure 40: Economic Indicators, China, Imports ($tn), 2008-2014
Figure 41: Economic Indicators, China, Exports ($tn), 2008-2014
Figure 42: Economic Indicators, China, Government Structural Balance ($bn), 2008-2014
Figure 43: Economic Indicators, China, General Government Gross Debt ($tn), 2008-2014
Figure 44: Economic Indicators, China, Major Industries, GDP by Production ($tn), 2013
Figure 45: Demographics, China, Population (billion), 2008-2014
Figure 46: Demographics, China, Population Forecast (bn), 2015-2020
Figure 47: Demographics, China, Population, Urban and Rural Population (%), 2008-2014
Figure 48: Demographics, China, Population Distribution by Age Group (%), 2008-2014
Figure 49: Demographics, China, Population Distribution by Age Group Forecast (%), 2015-2020
Figure 50: Demographics, China, Birth Rate (per 1,000 Population), 2008-2014
Figure 51: Demographics, China, Mortality (per 1,000 Population), 2008-2014
Figure 52: Demographics, China, Major Causes of Mortality (per 1,000 population), 2011
Figure 53: Demographics, China, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008-2014
Figure 54: Demographics, China, Immunization (%), 2008-2014
Figure 55: Demographics, China, Main Causes of Male Mortality (%), 2011
Figure 56: Demographics, China, Major Causes of Female Mortality (%), 2011
Figure 57: Demographics, China, Gender Ratio (Males per 100 Females), 2008-2014
Figure 58: Demographics, China, Life Expectancy (Years), 2008-2014
Figure 59: Demographics, China, Student Enrollment by Level of Education (million), 2014
Figure 60: Demographics, China, Unemployment Rate in Urban Areas (%), 2008-2014
Figure 61: Demographics, China, Major Diseases, City Hospital In-Patients (%), 2011
Figure 62: Demographics, China, Major Diseases, Share of County Hospital In-Patients (%), 2011
Figure 63: Demographics, China, Major Diseases, DALY (per 100,000 Population), 2009
Figure 64: Healthcare Infrastructure, China, Hospitals, 2008-2014
Figure 65: Healthcare Infrastructure, China, Hospitals by Bed Number (%), 2011
Figure 66: Healthcare Infrastructure, China, Hospitals Beds (million), 2008-2014
Figure 67: Healthcare Infrastructure, China, Hospital Beds (per 1,000 Population), 2008-2014
Figure 68: Healthcare Infrastructure, China, Doctors (per 1,000 Population), 2008-2014
Figure 69: Healthcare Infrastructure, China, CO2 Emissions (Metric Tons per Capita), 2008-2014
Figure 70: Healthcare Infrastructure, China, PM10 Emissions (µg/m3), 2008-2014
Figure 71: Healthcare Infrastructure, China, Nurses (per 1,000 Population), 2008-2014
Figure 72: Healthcare Expenditure, China, Healthcare Expenditure (% of GDP), 2008-2014
Figure 73: Healthcare Expenditure, China, Public-Private Share of Healthcare Expenditure (%), 2008-2014
Figure 74: Healthcare Market, China, Opportunities and Challenges, 2014

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3D

Read More...

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposable

Read More...
Choose License Type
Single User - US $1995
Multi User - US $3990
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify